These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 6980571)

  • 21. A monoclonal antibody against altered LFA-1 induces proliferation and lymphokine release of cloned T cells.
    Pircher H; Groscurth P; Baumhütter S; Aguet M; Zinkernagel RM; Hengartner H
    Eur J Immunol; 1986 Feb; 16(2):172-81. PubMed ID: 2420606
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The molecular basis for cytolytic T lymphocyte function: analysis with blocking monoclonal antibodies.
    Martz E; Davignon D; Kürzinger K; Springer TA
    Adv Exp Med Biol; 1982; 146():447-68. PubMed ID: 6980570
    [TBL] [Abstract][Full Text] [Related]  

  • 23. T lymphocyte-mediated cytolysis - a comprehensive theory. I. The mechanism of CTL-mediated cytolysis.
    Berke G; Clark WR
    Adv Exp Med Biol; 1982; 146():57-68. PubMed ID: 6980576
    [No Abstract]   [Full Text] [Related]  

  • 24. Heterogeneity of inhibition of cytolytic T lymphocyte clones by monoclonal anti-Lyt-2/3 antibodies: parallel effects on cytolysis, proliferation and lymphokine secretion.
    MacDonald HR; Glasebrook AL; Acuto O; Kelso A; Bron C; Cerottini JC
    Adv Exp Med Biol; 1982; 146():533-45. PubMed ID: 6980574
    [No Abstract]   [Full Text] [Related]  

  • 25. [Surface marker studies on lymphoma and leukemia cells with microcytotoxicity test using the UCLA Monoclonal Antibody Tray 5].
    Toki H; Okabe K; Kimura Y; Fujii M; Tamai M; Moriwaki S; Yamamoto Y
    Gan No Rinsho; 1985 Apr; 31(4):409-13. PubMed ID: 3874297
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cell membrane-mediated cytolysis by membranes from noncytolytic cells.
    Kahn-Perles B; Golstein P
    Eur J Immunol; 1978 Jan; 8(1):71-5. PubMed ID: 305851
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phenethyl isothiocyanate promotes immune responses in normal BALB/c mice, inhibits murine leukemia WEHI-3 cells, and stimulates immunomodulations in vivo.
    Tsou MF; Tien N; Lu CC; Chiang JH; Yang JS; Lin JP; Fan MJ; Lu JJ; Yeh SP; Chung JG
    Environ Toxicol; 2013 Mar; 28(3):127-36. PubMed ID: 21626647
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lyt-2-/Lyt 3- variants of a cloned cytolytic T cell line lack an antigen receptor functional in cytolysis.
    Dialynas DP; Loken MR; Glasebrook AL; Fitch FW
    J Exp Med; 1981 Mar; 153(3):595-604. PubMed ID: 6788878
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Monoclonal antibodies defining distinctive human T cell surface antigens.
    Kung P; Goldstein G; Reinherz EL; Schlossman SF
    Science; 1979 Oct; 206(4416):347-9. PubMed ID: 314668
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Participation of T-lymphocytes in the curative effect of a novel synthetic polyamine analogue, N,N'-bis[3-(ethylamino)propyl]-1,7-heptanediamine, against L1210 leukemia in vivo.
    Bowlin TL; Prakash NJ; Edwards ML; Sjoerdsma A
    Cancer Res; 1991 Jan; 51(1):62-6. PubMed ID: 1988107
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cytotoxic T lymphocyte-mediated lysis via the Fc receptor of target cells.
    Staerz UD; Bevan MJ
    Eur J Immunol; 1985 Dec; 15(12):1172-7. PubMed ID: 2935404
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dynamics of generation of antigen loss variants from L1210 murine leukemia clones detected by a tumor-specific T-cell clone.
    Nagase F; Rahman SM; Yokochi T; Kawashima K; Isobe K; Yoshida T; Nagura E; Nakashima I
    Cancer Res; 1987 Dec; 47(24 Pt 1):6494-9. PubMed ID: 3499976
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Surface structures involved in target recognition by human cytotoxic T lymphocytes.
    Meuer SC; Hussey RE; Hodgdon JC; Hercend T; Schlossman SF; Reinherz EL
    Science; 1982 Oct; 218(4571):471-3. PubMed ID: 6981845
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential antigenic expression of the DBA/2 lymphoma L1210 and its sublines: cross-reactivity with C3H mammary tumors as defined by syngeneic monoclonal antibodies.
    Rapp L; Fuji H
    Cancer Res; 1983 Jun; 43(6):2592-9. PubMed ID: 6342755
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characteristics of a monoclonal antibody (WT-31) that recognizes a common epitope on the human T cell receptor for antigen.
    Spits H; Borst J; Tax W; Capel PJ; Terhorst C; de Vries JE
    J Immunol; 1985 Sep; 135(3):1922-8. PubMed ID: 2410507
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cytochemical characterization of mouse L1210 leukemia.
    Kawiak J; Skórski T; Ciechanowicz A; Zylińska M; Seidel HJ; Kawalec M; Gnatowski B; Czarnomska A
    Immunol Invest; 1988; 17(6-7):543-50. PubMed ID: 2466781
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serological identification of viral and virus-related antigens on DBA/2 mouse leukemia lymphocytes.
    Steuden I; Radzikowski C; Zak-Nejmark T
    Arch Immunol Ther Exp (Warsz); 1979; 27(1-2):187-207. PubMed ID: 220930
    [TBL] [Abstract][Full Text] [Related]  

  • 38. T cell nature and heterogeneity of recognition structures of human natural killer (NK) cells.
    Fast LD; Beatty P; Hansen JA; Newman W
    J Immunol; 1983 Nov; 131(5):2404-10. PubMed ID: 6415167
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A new recombinant single chain trispecific antibody recruits T lymphocytes to kill CEA (carcinoma embryonic antigen) positive tumor cells in vitro efficiently.
    Wang XB; Zhao BF; Zhao Q; Piao JH; Liu J; Lin Q; Huang HL
    J Biochem; 2004 Apr; 135(4):555-65. PubMed ID: 15115782
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunogenicity and amplifier cell production by tumor vaccines enhanced by concanavalin A.
    Kataoka T; Oh-Hashi F; Sakurai Y
    Gan; 1982 Apr; 73(2):193-205. PubMed ID: 6811360
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.